DurgicalDurgical
EN
Open the app

Dopamine-antagonist antiemetics and prokinetics !

Drugs that block dopamine D2 receptors in the vomiting centre and, some of them, speed up the stomach. Movement side effects are the price.

Updated 2026-11-01

What they are

Metoclopramide, domperidone and the phenothiazine prochlorperazine block D2 receptors in the chemoreceptor trigger zone. Metoclopramide and domperidone are also prokinetics: they speed gastric emptying and are used in gastroparesis.

Mechanism of action

The chemoreceptor trigger zone in the area postrema lies outside the blood–brain barrier and is rich in D2 receptors; dopamine there triggers nausea. Blocking D2 receptors at that site reduces vomiting. In the stomach, dopamine slows motility; D2 blockade removes that brake, so antral contractions grow, the pylorus relaxes and the stomach empties faster. Drugs that cross into the brain also block D2 receptors in the basal ganglia, which explains dystonia, parkinsonism, akathisia and tardive dyskinesia; domperidone barely crosses the blood–brain barrier.

Target: Dopamine D2 receptor

Drugs in this class

Others in the class

  • Droperidol
  • Promethazine
  • Haloperidol (off-label as an antiemetic)

Test yourself

Think of the answer, then tap the question to see it.

Why can a D2 antagonist act on the chemoreceptor trigger zone even if it barely enters the brain?

The trigger zone in the area postrema lies outside the blood–brain barrier, so drugs such as domperidone reach its D2 receptors.

Which two actions make metoclopramide useful in diabetic gastroparesis?

It speeds gastric emptying (stronger antral contractions, relaxed pylorus) and it reduces nausea by blocking D2 receptors in the trigger zone.

A young adult develops a sudden twisted neck and eye deviation after an IV antiemetic. Which class is the likely cause?

A dopamine D2 antagonist such as metoclopramide or prochlorperazine (acute dystonic reaction).

Add to my cards (3)

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - METOCLOPRAMIDE injection, solution (DailyMed (U.S. National Library of Medicine), 2026); Nausea and Vomiting - Gastroenterology - MSD Manual Professional Edition (MSD Manual Professional Edition, 2025); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.